## Immunological Mechanism of Acute Penicillin Anaphylaxis ### Clinical Presentation Analysis The patient's presentation—**acute onset within 15 minutes** of drug administration, **urticaria, angioedema, stridor, and hypotension**—is pathognomonic for **Type I hypersensitivity (immediate hypersensitivity)**. The positive skin prick test with penicilloyl-polylysine (PPL, a major determinant of penicillin) confirms the presence of penicillin-specific IgE. ### Mechanism: IgE-Mediated Anaphylaxis **Key Point:** Type I hypersensitivity is an IgE-mediated reaction occurring within **seconds to minutes** of allergen exposure. Penicillin acts as a hapten, conjugating to carrier proteins (e.g., serum albumin) to form immunogenic complexes that stimulate B cells to produce penicillin-specific IgE. ### Pathophysiology Steps 1. **Sensitization phase** (prior exposure, often subclinical): - Penicillin-protein conjugate is processed by antigen-presenting cells - Th2 cells are activated, promoting B cell class-switching to IgE production - Penicillin-specific IgE binds to high-affinity IgE receptors (FcεRI) on mast cells and basophils 2. **Re-exposure (challenge phase)**: - Penicillin cross-links IgE molecules on mast cell/basophil surface - This triggers rapid degranulation, releasing preformed mediators: **histamine, tryptase, heparin, chymase** - Newly synthesized mediators (leukotrienes, prostaglandins, bradykinin) are generated 3. **Clinical effects**: - **Histamine** → urticaria, angioedema, bronchospasm, vasodilation (hypotension) - **Leukotrienes (LTC₄, LTD₄, LTE₄)** → increased vascular permeability, smooth muscle contraction - **Bradykinin** → pain, edema, hypotension ### Diagnostic Confirmation **High-Yield:** Skin prick testing with **PPL (major determinant)** and **native penicillin G (minor determinants)** is the gold standard for confirming penicillin-specific IgE. A positive test indicates prior sensitization and ongoing risk of anaphylaxis. ### Clinical Pearl Although this patient had no documented prior penicillin allergy, **subclinical sensitization** (e.g., from environmental exposure, prior oral amoxicillin, or cross-reactivity with other β-lactams) can occur. The rapid onset and severity suggest high-affinity IgE with substantial mast cell burden. ```mermaid flowchart TD A[Penicillin exposure]:::outcome --> B[Hapten-carrier complex formation]:::action B --> C[Th2 activation & B cell class-switching]:::action C --> D[IgE production & binding to FcεRI on mast cells/basophils]:::action E[Re-exposure to penicillin]:::outcome --> F{IgE cross-linking?}:::decision F -->|Yes| G[Mast cell/basophil degranulation]:::action G --> H[Histamine, tryptase, leukotrienes, bradykinin release]:::action H --> I[Urticaria, angioedema, bronchospasm, hypotension]:::urgent J[Skin prick test with PPL/penicillin G]:::action --> K[Positive = IgE-mediated sensitization]:::outcome ``` ## Mnemonic: **FAST** (Type I Hypersensitivity Features) - **F**ast onset (seconds to minutes) - **A**ntibody IgE-mediated - **S**ensitization required (prior exposure) - **T**est positive: skin prick, specific IgE, tryptase elevation ## Why This Is Type I (Not Type II, III, or IV) | Feature | Type I | Type II | Type III | Type IV | |---------|--------|---------|----------|----------| | **Onset** | Seconds–minutes | Hours–days | 3–10 days | 24–72 hours | | **Antibody** | IgE | IgG, IgM | IgG, IgM | None (T cell) | | **Mechanism** | Mast cell degranulation | Cytotoxicity, opsonization | Immune complex deposition | T cell infiltration | | **Penicillin allergy** | ✓ Anaphylaxis | Drug-induced hemolytic anemia | Serum sickness-like | Contact dermatitis | | **Skin test** | Immediate wheal-flare | Negative | Negative | Delayed induration | **Warning:** Do NOT confuse Type I with Type IV delayed hypersensitivity (e.g., contact dermatitis to penicillin ointment), which presents 24–72 hours later with pruritic erythema and infiltration, not anaphylaxis.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.